Clinical ThyroidologyVol. 34, No. 9
Thyroid Cancer
Bone Density Testing Intervals in TSH Suppression Therapy for Differentiated Thyroid Cancer
Sanaa Badour and Naykky Singh Ospina
Published Online:15 Sep 2022
doi.org/10.1089/ct.2022;34....
This article looks at duration of TSH suppression in thyroid cancer treated patients versus controls. It shows that onset of osteoporosis for the TC group was 1% greater than for controls. That is 13.6 v 14.7%. Or, an additional 1 per 100 people. It's interesting that the occurence of OP by TSH suppression is no big deal compared with controls, as has been found before. The authors admit the complexity of a link if any.